Mereo BioPharma Group plc SEC filings MREO

Mereo BioPharma Group plc has 439 filings in SEC EDGAR's recent list, going back to Dec 1, 2017. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 19, 2026 (listing notice). The company's fiscal year ends on December 31.

Mereo BioPharma Group plc SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 28, 2026 —
8-K Current report
Listing notice
Aug 19, 2026 Aug 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 11, 2026 Aug 11, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Aug 11, 2026 Aug 11, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 14, 2026 —
8-K Current report
Shareholder vote results
May 14, 2026 May 14, 2026
8-K/A Amended current report
Results of operations
May 12, 2026 May 12, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Acquisition or sale of assets
May 12, 2026 May 12, 2026
ARS Annual report to shareholders Apr 9, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 9, 2026 Apr 8, 2026
PRE 14A Preliminary proxy statement Mar 27, 2026 Mar 27, 2026
8-K Current report
Officer or director change
Mar 27, 2026 Mar 26, 2026
10-K Annual report Mar 19, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 19, 2026 Mar 19, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Listing notice
Feb 17, 2026 Feb 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
4 Insider transaction Feb 2, 2026 Feb 1, 2026
4 Insider transaction Feb 2, 2026 Feb 1, 2026
4 Insider transaction Feb 2, 2026 Feb 1, 2026
4 Insider transaction Feb 2, 2026 Feb 1, 2026
4 Insider transaction Feb 2, 2026 Feb 1, 2026
S-8 Employee stock plan registration Feb 2, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jan 12, 2026 Jan 12, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 9, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jan 6, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Dec 29, 2025 Dec 29, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
8-K Current report
Other events
Jul 10, 2025 Jul 9, 2025
SCHEDULE 13G Ownership over 5% (passive) Jun 11, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
8-K Current report
Shareholder vote results
May 14, 2025 May 13, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
ARS Annual report to shareholders Apr 8, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 8, 2025 May 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 4, 2025 —
10-K Annual report Mar 26, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 26, 2025 Mar 26, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
4 Insider transaction Feb 6, 2025 Feb 5, 2025
4 Insider transaction Feb 6, 2025 Feb 5, 2025
4 Insider transaction Feb 6, 2025 Feb 5, 2025
4 Insider transaction Feb 6, 2025 Feb 5, 2025
4 Insider transaction Feb 6, 2025 Feb 5, 2025
4 Insider transaction Feb 6, 2025 Feb 5, 2025
4 Insider transaction Feb 6, 2025 Feb 5, 2025
4 Insider transaction Feb 6, 2025 Feb 5, 2025
4 Insider transaction Jan 28, 2025 Jan 25, 2025
4 Insider transaction Jan 28, 2025 Jan 25, 2025
4 Insider transaction Jan 28, 2025 Jan 25, 2025
4 Insider transaction Jan 28, 2025 Jan 25, 2025
4 Insider transaction Jan 28, 2025 Jan 25, 2025
S-8 Employee stock plan registration Jan 23, 2025 —
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 6, 2024 —
EFFECT Filing Dec 4, 2024 —
424B3 Prospectus Dec 4, 2024 —
CORRESP Letter to the SEC Dec 3, 2024 —
UPLOAD Letter from the SEC Dec 2, 2024 —
S-3 Shelf registration Nov 25, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Material agreement, Results of operations
Nov 12, 2024 Nov 8, 2024
4 Insider transaction Sep 16, 2024 Sep 12, 2024
4 Insider transaction Sep 16, 2024 Sep 12, 2024
4 Insider transaction Sep 16, 2024 Sep 12, 2024
4 Insider transaction Sep 16, 2024 Sep 12, 2024
4 Insider transaction Sep 16, 2024 Sep 12, 2024
4 Insider transaction Sep 13, 2024 Sep 11, 2024
4 Insider transaction Sep 13, 2024 Sep 11, 2024
4 Insider transaction Sep 13, 2024 Sep 11, 2024
4 Insider transaction Sep 13, 2024 Sep 11, 2024
4 Insider transaction Sep 13, 2024 Sep 11, 2024
144 Notice of proposed sale Sep 12, 2024 —
144 Notice of proposed sale Sep 12, 2024 —
144 Notice of proposed sale Sep 12, 2024 —
144 Notice of proposed sale Sep 12, 2024 —
144 Notice of proposed sale Sep 12, 2024 —
4 Insider transaction Aug 23, 2024 Aug 22, 2024
144 Notice of proposed sale Aug 22, 2024 —
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
SC 13G Ownership over 5% (passive) Jul 11, 2024 —
4 Insider transaction Jun 27, 2024 Jun 25, 2024
4 Insider transaction Jun 27, 2024 Jun 25, 2024
4 Insider transaction Jun 27, 2024 Jun 25, 2024
4 Insider transaction Jun 27, 2024 Jun 25, 2024
4 Insider transaction Jun 27, 2024 Jun 25, 2024
4 Insider transaction Jun 25, 2024 Jun 21, 2024
4 Insider transaction Jun 25, 2024 Jun 21, 2024
4 Insider transaction Jun 25, 2024 Jun 21, 2024
4 Insider transaction Jun 25, 2024 Jun 21, 2024
4 Insider transaction Jun 25, 2024 Jun 21, 2024
144/A Filing Jun 24, 2024 —
144/A Filing Jun 24, 2024 —
144/A Filing Jun 24, 2024 —
144/A Filing Jun 24, 2024 —
144/A Filing Jun 24, 2024 —
144 Notice of proposed sale Jun 20, 2024 —
144 Notice of proposed sale Jun 20, 2024 —
144 Notice of proposed sale Jun 20, 2024 —
144 Notice of proposed sale Jun 20, 2024 —
144 Notice of proposed sale Jun 20, 2024 —
4 Insider transaction Jun 17, 2024 Jun 17, 2024
SC 13D/A Amended ownership over 5% (active) Jun 17, 2024 —
4 Insider transaction Jun 17, 2024 Jun 17, 2024
4 Insider transaction Jun 17, 2024 Jun 17, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Jun 14, 2024 Jun 14, 2024
424B5 Prospectus supplement Jun 14, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Jun 12, 2024 Jun 11, 2024
4/A Filing Jun 11, 2024 May 22, 2024
4 Insider transaction May 23, 2024 May 22, 2024
144 Notice of proposed sale May 23, 2024 —
8-K Current report
Shareholder vote results
May 23, 2024 May 23, 2024
EFFECT Filing May 22, 2024 —
CORRESP Letter to the SEC May 21, 2024 —
UPLOAD Letter from the SEC May 20, 2024 —
S-3 Shelf registration May 15, 2024 —
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
ARS Annual report to shareholders Apr 24, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 24, 2024 May 23, 2024
SC 13D/A Amended ownership over 5% (active) Apr 16, 2024 —
8-K Current report
Material agreement
Apr 15, 2024 Apr 15, 2024
10-K Annual report Mar 27, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 27, 2024 Mar 27, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Feb 9, 2024 Feb 8, 2024
4 Insider transaction Feb 9, 2024 Feb 8, 2024
4 Insider transaction Feb 9, 2024 Feb 8, 2024
4 Insider transaction Feb 9, 2024 Feb 8, 2024
4 Insider transaction Feb 9, 2024 Feb 8, 2024
4 Insider transaction Feb 9, 2024 Feb 8, 2024
4 Insider transaction Feb 9, 2024 Feb 8, 2024
4 Insider transaction Feb 9, 2024 Feb 8, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2024 —
SC 13G Ownership over 5% (passive) Feb 5, 2024 —
4 Insider transaction Jan 26, 2024 Jan 25, 2024
4 Insider transaction Jan 26, 2024 Jan 25, 2024
4 Insider transaction Jan 26, 2024 Jan 25, 2024
4 Insider transaction Jan 26, 2024 Jan 25, 2024
4 Insider transaction Jan 26, 2024 Jan 25, 2024
S-8 Employee stock plan registration Jan 23, 2024 —
8-K Current report
Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
3 Initial insider ownership Jan 2, 2024 Jan 1, 2024
8-A12B/A Filing Dec 18, 2023 —
6-K Current report (foreign issuer) Dec 18, 2023 Dec 18, 2023
6-K Current report (foreign issuer) Nov 29, 2023 Nov 29, 2023
SC 13D/A Amended ownership over 5% (active) Nov 20, 2023 —
6-K Current report (foreign issuer) Nov 16, 2023 Nov 16, 2023
SC 13D/A Amended ownership over 5% (active) Nov 15, 2023 —
SC 13D/A Amended ownership over 5% (active) Nov 13, 2023 —
SC 13D/A Amended ownership over 5% (active) Nov 8, 2023 —
SC 13D/A Amended ownership over 5% (active) Nov 6, 2023 —
SC 13D/A Amended ownership over 5% (active) Nov 2, 2023 —
SC 13D/A Amended ownership over 5% (active) Oct 31, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MREO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
London
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1719714

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.